STRATA Skin Sciences amends credit agreement, removes 2023 revenue covenants

STRATA Skin Sciences, Inc.

Amendment No. 4 removes minimum revenue requirements for 2023 and introduces future financial covenants.
Effective February 20, 2024; aligns credit terms with current and projected business operations.
Enhances liquidity and financial flexibility to support operational and capital needs.
CEO Dolev Rafaeli states amendment strengthens partnership with MidCap and enables strategic initiatives.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.